[Treatment of neurosympathetic dystonia with the methylperidol-hexadiphane combination].
D000293:Adolescent; D000328:Adult; D001381:Azepines / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use
D001381:Azepines; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics
Le traitement des dystonies neuro-végétives par l'association méthylpéridol-hexadiphane.